Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree

Germline mutations have been identified in a small number of hereditary cancers, but the genetic predisposition for many familial cancers remains to be elucidated.

• Publication year

  2024

• Venue

  Cancer Medicine

• Publication date

  2024-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cam4.7394PMID 38970307PMCID 11226725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers

  2023cited by this paper
• Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies

  2023cited by this paper
• Are population level familial risks and germline genetics meeting each other?

  2023influential reference
• Cancer epigenetics in clinical practice

  2022cited by this paper
• Zinc finger protein 831 promotes apoptosis and enhances chemosensitivity in breast cancer by acting as a novel transcriptional repressor targeting the STAT3/Bcl2 signaling pathway

  2022cited by this paper
• Substitution mutational signatures in whole-genome–sequenced cancers in the UK population

  2022cited by this paper
• Cancer incidence and mortality in China, 2016

  2022cited by this paper
• SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway

  2022cited by this paper
• PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop

  2022cited by this paper
• Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome

  2022cited by this paper
• Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology

  2021cited by this paper
• Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response

  2021cited by this paper
• Familial Risks and Proportions Describing Population Landscape of Familial Cancer

  2021cited by this paper
• HERC Ubiquitin Ligases in Cancer

  2020cited by this paper
• Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden

  2020cited by this paper
• Rare copy number variants in over 100,000 European ancestry subjects reveal multiple disease associations

  2020cited by this paper
• Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer

  2020cited by this paper
• Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: a case-control study

  2020cited by this paper
• Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

  2020cited by this paper
• Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

  2019cited by this paper
• Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma

  2019cited by this paper
• PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway

  2019cited by this paper
• Whole-Genome Sequencing in Cancer.

  2018cited by this paper
• Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes

  2018cited by this paper
• Pathogenic Germline Variants in 10,389 Adult Cancers.

  2018cited by this paper
• Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes.

  2018cited by this paper
• The repertoire of mutational signatures in human cancer

  2018cited by this paper
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

  2017cited by this paper
• A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

  2017cited by this paper
• Epigenetic control of gene expression: Potential implications for cancer treatment.

  2017cited by this paper
• Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1.

  2016cited by this paper
• Germline Mutations in Predisposition Genes in Pediatric Cancer.

  2015cited by this paper
• Patterns and functional implications of rare germline variants across 12 cancer types

  2015cited by this paper
• Using epigenomic studies in monozygotic twins to improve our understanding of cancer.

  2014cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• Core promoter analysis of porcine Six1 gene and its regulation of the promoter activity by CpG methylation.

  2013cited by this paper
• DNA hypomethylation and hemimethylation in cancer.

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at Remission

  2012cited by this paper
• The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.

  2012cited by this paper
• Genome sequencing and cancer.

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• HERC2 is an E3 ligase that targets BRCA1 for degradation.

  2010cited by this paper
• WT1 protein expression in childhood acute leukemia

  2008cited by this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cited by this paper
• An Epigenetic Approach to Cancer Etiology

  2007cited by this paper
• A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.

  2006cited by this paper
• Highly penetrant hereditary cancer syndromes

  2004cited by this paper
• Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

  2000cited by this paper
• The multistep nature of cancer.

  1993cited by this paper

• Single-Nucleotide Polymorphisms Related to Multiple Myeloma Risk: A Systematic Review and Meta-Analysis

  2025cites this paper
• Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways

  2025cites this paper